Skip to main content
Premium Trial:

Request an Annual Quote

20 Percent Boost in Agilent’s Life Science Sales Drives 7 Percent Q2 Profit Spike

NEW YORK (GenomeWeb News) - Agilent Technologies said late yesterday that fiscal second-quarter revenues increased 6 percent as R&D spending increased 1 percent and profit climbed 7 percent.     
Revenue for the company's Bio-Analytical Measurement segment increased 15 percent to $428 million from $372 million year over year and Life Sciences revenue was up 20 percent to $194 million, the company said.
The company attributed the growth to strong sales of liquid chromatography and LC/mass spectrometry instruments and its comparative genomic hybridization microarrays. 
Total receipts for the three months ended April 31 increased to $1.32 billion from $1.24 billion year over year.
R&D spending increased to $173 million from $172 million year over year.
The company said net income rose to $123 million from $115 million in the year-ago period.
Agilent said it had around $2.05 billion in cash and cash equivalents as of April 31.
For the third quarter of 2007, the company said it expects revenues between $1.36 billion and $1.4 billion.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.